{"podcast":{"title":"Disease Du Jour","slug":"disease-du-jour-15968","podcast_index_feed_id":15968,"rss_url":"https://feeds.captivate.fm/diseasedujour/","website_url":"https://equimanagement.com","image_url":"https://artwork.captivate.fm/126f0c3f-a92c-4901-8530-b63a036b499f/QMyBDjRnvUHzuXg1I0R4gBaH.jpg","author":"Disease DuJour","episode_count":193,"summary":"EquiManagement’s podcast Disease Du Jour, where we delve into the research and current best practices for a variety of equine health problems with industry experts. Hosted on Acast. See acast.com/privacy for more information.","last_synced_at":"2026-09-03T20:23:50.594395+00:00","page_url":"https://stenobird.com/podcast/disease-du-jour-15968"},"episode":{"title":"Ep. 171: Pioneer, Generic, Compounded, and Counterfeit Animal Drugs with Stephanie Batliner","slug":"ep-171-pioneer-generic-compounded-and-counterfeit-animal-drugs-with-stephanie-batliner","published_at":"2025-12-04T13:00:00+00:00","page_url":"https://stenobird.com/podcast/disease-du-jour-15968/ep-171-pioneer-generic-compounded-and-counterfeit-animal-drugs-with-stephanie-batliner","show_page_url":"https://stenobird.com/podcast/disease-du-jour-15968","url":"https://staging.equimanagement.com/pioneer-generic-compounded-and-counterfeit-animal-drugs-with-stephanie-batliner","audio_url":"https://episodes.captivate.fm/episode/4abdcf9f-0ced-49ef-ab67-0fc9f176d0c0.mp3","summary":"In this episode, Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda, joined us to discuss  the FDA approval process for pioneer and generic animal drugs. She also discussed veterinary devices, pharmacy compounding, counterfeit drugs, and more.  This episode of Disease Du Jour is brought to you by Bimeda. GUESTS AND LINKS - EPISODE 171 Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com) Guest: Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda Podcast Website:   Disease Du Jour This episode of Disease Du Jour podcast is brought to you by Bimeda . Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)","meta_description":"In this episode, Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda, joined us to discuss the FDA approval process fo…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1799,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/disease-du-jour-15968/episodes/ep-171-pioneer-generic-compounded-and-counterfeit-animal-drugs-with-stephanie-batliner/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/disease-du-jour-15968/ep-171-pioneer-generic-compounded-and-counterfeit-animal-drugs-with-stephanie-batliner.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}